Showing 11,841 - 11,860 results of 67,847 for search '(( 5 g decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.52s Refine Results
  1. 11841

    Synthesis and Mechanisms of Black Polyimide Films with High Mechanical and Dielectric Strength: Effects of Multicomponent Polymerization and Doping by Changqing He (19516063)

    Published 2024
    “…Herein, we propose a novel preparation method to eliminate the above trade-off effect. …”
  2. 11842
  3. 11843

    Low-Temperature Methane Combustion Using Ozone over Coβ Catalyst by Shunsaku Yasumura (8519667)

    Published 2024
    “…The resulting path toward CO<sub>2</sub> formation shows an activation energy of 73 kJ/mol for the rate-determining step and an exothermicity of 1025 kJ/mol, which supports the experimental results. During a long-term catalytic test for 160 h without external heating, the CH<sub>4</sub> conversion gradually decreases from 80 to 40%, but the conversion fully recovers after dehydration at 500 °C (0.5 h). …”
  4. 11844
  5. 11845
  6. 11846

    Figure S5_2 from Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma by Joseph J. Caumanns (15010014)

    Published 2023
    “…<p>Supplementary Figure 5 | Clustering (n=106) and survival analysis (n=70) on kinome mutations and CNA. …”
  7. 11847

    Figure S5_1 from Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma by Joseph J. Caumanns (15010014)

    Published 2023
    “…<p>Supplementary Figure 5 | Clustering (n=106) and survival analysis (n=70) on kinome mutations and CNA. …”
  8. 11848
  9. 11849

    Initial treatment regimen. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  10. 11850

    Patients baseline characteristics. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  11. 11851

    Maintenance regimen and adverse event management. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  12. 11852
  13. 11853
  14. 11854

    Decreased Collagen Type I is Associated with Increased Metalloproteinase-2 Activity and Protein Expression of Leptin in the Myocardium of Obese Rats by Danielle Cristina Tomaz da Silva-Bertani (8651283)

    Published 2020
    “…Our previous study showed decreased protein levels of myocardial collagen type I in obese rats fed a high-fat diet for 34 weeks. …”
  15. 11855

    Influence of Precursor Solution Composition on the Electrical Properties of Solution-Processed Indium Tin Oxide Thin Films by Jingwei Zhang (288128)

    Published 2025
    “…The results reveal that incorporating nitrate anion-based precursors and Sn (II)-based precursors in the solutions leads to the ITO film with a low resistivity of 3.5 × 10<sup>–3</sup> Ω cm. …”
  16. 11856

    Influence of Precursor Solution Composition on the Electrical Properties of Solution-Processed Indium Tin Oxide Thin Films by Jingwei Zhang (288128)

    Published 2025
    “…The results reveal that incorporating nitrate anion-based precursors and Sn (II)-based precursors in the solutions leads to the ITO film with a low resistivity of 3.5 × 10<sup>–3</sup> Ω cm. …”
  17. 11857
  18. 11858
  19. 11859

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
  20. 11860

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”